研究業績
令和2年度（2020年度）
医学医療系業績
1. Shintaro Akiyama, Akihiro Yamada, Dejan Micic, Atsushi Sakuraba. The risk of respiratory tract infections and interstitial lung disease with interleukin 12/23 and interleukin 23 antagonists in patients with autoimmune diseases: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. 2021 Mar; 84(3): 676-690.
2. Zhang X, Yamamoto Y, Wang X, Sato M, Imanishi M, Sugaya A, Hirose M, Endo S, Moriwaki T, Yamato K, Hyodo I. MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53. Anticancer Res. 2021 Mar;41(3):1475-1483.
3. Ueno M, Morizane C, Furukawa M, Sakai D, Komatsu Y, Nakai Y, Tsuda M, Ozaka M, Mizuno N, Muto M, Fukutomi A, Ikeda M, Tsuji A, Katanuma A, Moriwaki T, Kajiwara T, Ishii H, Negoro Y, Shimizu S, Nemoto N, Kobayashi S, Makino K, Furuse J. A randomized, double-blind, phase II study of oral histone deacetylase inhibitor resminostat plus S-1 versus placebo plus S-1 in biliary tract cancers previously treated with gemcitabine plus platinum-based chemotherapy. Cancer Med. 2021 Mar;10(6):2088-2099.
4. Fujitani K, Shitara K, Takashima A, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Kimura Y, Amagai K, Hosaka H, Komatsu Y, Shimada K, Kawabata R, Ohdan H, Kodera Y, Nakamura M, Nakajima TE, Miyata Y, Moriwaki T, Kusumoto T, Nishikawa K, Ogata K, Shimura M, Morita S, Koizumi W. Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial. Gastric Cancer. 2021 Mar;24(2):467-476.
5. Matsuishi Y, Shimojo N, Hoshino H, Enomoto Y, Mathis BJ, Oh S, Kawano S, Myoenzono K, Maeda S, Shoda J, Inoue S, Inoue Y. Establishment of a murine, lipopolysaccharide-induced sepsis model for testing anaerobic exercise thresholds and early mobilization. Medicine in Drug Delivery.2021 Mar; 9: 100074
6. I.Sekine, Y.Yamamoto, T.Suzuki, H.Suzuki. Malignant Pleural Mesothelioma in Patients Who Previously Received Radiotherapy for their First Malignant Tumor. Intern Med.2021 Mar; 60, 663-665.
7. Uchida F, Oh S, Shida T, Suzuki H, Yamagata K, Mizokami Y, Bukawa H, Shoda J. Exercise Practice Induces Beneficial Effects on Periodontal Disease Conditions – Oral Microbiota and Saliva Analysis. Int J Environ Res & Public Health. 2021 Mar;18: 3470.
8. F.Uchida, S.Oh, T.Shida, H.Suzuki, K.Yamagata, Y.Mizokami, H.Bukawa, K.Tanaka, J.Shoda. Effects of exercise on the oral microbiota and saliva of patients with non-alcoholic fatty liver disease. Int J Environ Res Public Health. 2021 Mar 26;18(7):3470.
9. Hatta W, Tsuji Y, Yoshio T, Kakushima N, Hoteya S, Doyama H, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Koike T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Sugimoto M, Yamaguchi S, Michida T, Yada T, Asahina Y, Narasaka T, Kuribasyashi S, Kiyotoki S, Mabe K, Nakamura T, Nakaya N, Fujishiro M, Masamune A. Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score. Gut. 2021 Mar;70(3):476-484. doi: 10.1136/gutjnl-2019-319926. Epub 2020 Jun 4.
10. Chida K, Kotani D, Moriwaki T, Fukuoka S, Masuishi T, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Komoda M, Makiyama A, Denda T, Hatachi Y, Suto T, Sugimoto N, Enomoto M, Ishikawa T, Kashiwada T, Ando K, Yuki S, Okita Y, Kusaba H, Sakai D, Okamoto K, Tamura T, Yamashita K, Gosho M, Shimada Y. Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS). Front Oncol. 2021 Mar 8;11:576036. eCollection 2021.
11. Narita Y, Shoji H, Kawai S, Mizukami T, Nakamura M, Moriwaki T, Yamanaka T, Sunakawa Y, Kawakami H, Nishina T, Misumi T, Muro K. REVIVE study: a prospective observational study in chemotherapy after nivolumab therapy for advanced gastric cancer. Future Oncol. 2021 Mar;17(8):869-875. doi: 10.2217/fon-2020-0621.
12. Fujitani K, Shitara K, Takashima A, Koeda K, Hara H, Na kayama N, Hironaka S, Nishikawa K, Kimura Y, Amagai K, Hosaka H, Komatsu Y, Shimada K, Kawabata R, Ohdan H, Kodera Y, Nakamura M, Nakajima TE, Miyata Y, Moriwaki T, Kusumoto T, Nishikawa K, Ogata K, Shimura M, Morita S, Koizumi W. Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial. Gastric Cancer. 2021 Mar;24(2):467-476
13. Uchida F, Oh S, Shida T, Suzuki H, Yamagata K, Mizokami Y, Bukawa H, Tanaka K, Shoda J. Effects of Exercise on the Oral Microbiota and Saliva of Patients with Non-Alcoholic Fatty Liver Disease. International Journal of Environmental Research and Public Health. 2021 Mar 26;18(7):3470
14. Shintaro Akiyama, Akihiro Yamada, Atsushi Sakuraba. Safety of non-tumor necrosis factor-targeted biologics in the COVID-19 pandemic. Journal of Medical Virology. 2021 Feb; 93(2): 714-716.
15. Suzuki H, Yamada T, Sugaya A, Ueyama S, Yamamoto Y, Moriwaki T, Hyodo I. Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden. Int J Clin Oncol. 2021 Feb;26(2):370-377.
16. Oh S, Tsujimoto T, Kim B, Uchida F, Iizumi S, Isobe T, Sakae T, Tanaka K, Shoda J. Weight loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD. JHEP . 2021 Feb 10;3(3):100253.
17. Katsukura N, Watanabe S, Shirasaki T, Hibiya S, Kano Y, Akahoshi K, Tanabe M, Kirimura S, Akashi T, Kitagawa M, Okamoto R, Watanabe M, Tsuchiya K*. Intestinal phenotype is maintained by Atoh1 in the cancer region of intraductal papillary mucinous neoplasm. Cancer Sci. 2021 Feb;112(2):932-944.
18. Nakamagoe K, Yamada T, Okune S, Moriwaki T, Tamaoka A. Fisher syndrome as an immune-related adverse event after using pembrolizumab but not nivolumab. Acta Neurol Belg. 2021 Feb;121：1381–1382
19. T Fujita, H Kurokawa, Z Han, Y Zhou, H Matsui, Josiane Ponou, Gjergj Dodbiba, Chunlin He &Yuezou Wei. Free radical degradation in aqueous solution by blowing hydrogen and carbon dioxide nanobubbles. Scientific Reports.2021 Feb; 11: Article number: 3068
20. Suzuki H, Yamada T, Sugaya A, Ueyama S, Yamamoto Y, Moriwaki T, Hyodo I. Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden. Int J Clin Oncol. 2021 Feb;26(2):370-377.
21. Nakamagoe, K., Yamada, T., Okune, S. et al. Fisher syndrome as an immune-related adverse event after using pembrolizumab but not nivolumab. Acta Neurol Belg.2021 Feb 28;121:1381-1382.
22. Sechang Oh, Takehiko Tsujimoto, Bokun Kim, Fumihiko Uchida, Hideo Suzuki, Seiichiro Iizumi, Tomonori Isobe, Takeji Sakae, Kiyoji Tanaka, Junichi Shoda. Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD, JHEP Reports.2021 Feb 10;3(3):100253.
23. Kuno R, Ito G, Kawamoto A, Hiraguri Y, Sugihara HY, Takeoka S, Nagata S, Takahashi J, Tsuchiya M, Anzai S, Mizutani T, Shimizu H, Yui S, Oshima S, Tsuchiya K, Watanabe M, Okamoto R. Notch and TNF-α signaling promote cytoplasmic accumulation of OLFM4 in intestinal epithelium cells and exhibit a cell protective role in the inflamed mucosa of IBD patients. Biochem Biophys Rep. 2021 Jan;25: 100906.
24. Tsuchiya M, Ito G, Hama M, Nagata S, Kawamoto A, Suzuki K, Shimizu H, Anzai S, Takahashi J, Kuno R, Takeoka S, Hiraguri Y, Sugihara HY, Mizutani T, Yui S, Oshima S, Tsuchiya K, Watanabe M, Okamoto R. Functional analysis of isoflavones using patient-derived human colonic organoids. Biochem Biophys Res Commun. 2021 Jan;542:40-47.
25. Aonuma E, Tamura A, Matsuda H, Asakawa T, Sakamaki Y, Otsubo K, Nibe Y, Onizawa M, Nemoto Y, Nagaishi T, Tsuchiya K, Nakamura T, Uo M, Watanabe M, Okamoto R, Oshima S. Nickel ions attenuate autophagy flux and induce transglutaminase 2 (TG2) mediated post-translational modification of SQSTM1/p62. Biochem Biophys Res Commun. 2021 Jan;542:17-23.
26. H.Suzuki, Y.Tokai, T.Yoshio, T.Tada. Artificial Intelligence for cancer detection of the upper gastrointestinal tract. Dig Endosc. 2021 Jan;33:254-262
27. T. Suzuki, Y. Yamamoto, N. Sakamoto, H. Suzuki, K. Tajiri, T. Ishizu, Y. Fujisawa, M. Noguchi, M. Ieda, Y. Hiramatsu, I. Sekine: Dramatic recovery from cardiovascular collapse: paclitaxel as an urgent treatment for primary cardiac angiosarcoma. Intern Med. 2021 Jan; 60:67-71.
28. Shintaro Akiyama, Victoria Rai, David T. Rubin. Pouchitis in Inflammatory Bowel Disease: A Review of Diagnosis, Prognosis, and Treatment. Intestinal Research 2021 Jan; 19(1): 1-11.
29. Simon J Hong, Noa K. Cleveland, Shintaro Akiyama, Samantha Zullow, Yangtian Yi, Seth R. Shaffer, Lisa B. Malter, Jordan E. Axelrad, Shannon Chang, David P. Hudesman, David T. Rubin. Real world effectiveness and safety of ustekinumab for ulcerative colitis from two tertiary IBD centers in the US. Crohn’s & Colitis 360. 2021 Jan; 3(1): 1-8.
30. Shintaro Akiyama, Akihiro Yamada, Yuga Komaki, Fukiko Komaki, Dejan Micic, Atsushi Sakuraba. Efficacy and safety of monoclonal antibodies against Clostridioides difficile toxins for prevention of recurrent Clostridioides difficile infection: A systematic review and meta-analysis. Journal of Clinical Gastroenterology 2021.Jan; 55(1): 43-51.
31. Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba. Response to ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Lee. Annals of the Rheumatic Diseases.2021 Jan; 0: 1.
32. Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba. Response to: ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Yang et al. Annals of the Rheumatic Diseases. 2021 Jan; 0: 1.
33. Hasegawa H, Taniguchi H, Nakamura Y, Kato T, Fujii S, Ebi H, Shiozawa M, Yuki S, Masuishi T, Kato K, Izawa N, Moriwaki T, Oki E, Kagawa Y, Denda T, Nishina T, Tsuji A, Hara H, Esaki T, Nishida T, Kawakami H, Sakamoto Y, Miki I, Okamoto W, Yamazaki K, Yoshino T. FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer. Cancer Sci. 2021 Jan;112(1):314-322.
34. Morikawa R, Nemoto Y, Yonemoto Y, Tanaka S, Takei Y, Oshima S, Nagaishi T, Tsuchiya K, Nozaki K, Mizutani T, Nakamura T, Watanabe M, Okamoto R. Intraepithelial Lymphocytes Suppress Intestinal Tumor Growth by Cell-to-Cell Contact via CD103/E-Cadherin Signal. Cell Mol Gastroenterol Hepatol. 2021 Jan 28;11(5):1483-1503.
35. Nagami Y, Sakai T, Yamamura M, Nakatani M, Katsuno T, Suekane T, Uno H, Minamino H, Okuyama M, Okamoto J, Kumamoto M, Noguchi A, Yamamori K, Takaishi O, Ochi M, Miyazaki T, Tsuji S, Ikehara H, Kawaguchi K, Hayashi T, Mannami T, Kakimoto K, Naito Y, Hashimoto S, Li Z, Komeda Y, Kishino T, Yamamoto Y, Iguchi M, Akamatsu T, Horii T, Miura K, Yamashina T, Sugihara Y, Watanabe N, Kiyotoki S, Fujii R, Murata M, Ono S, Narasaka T, Kitamura S, Kono M, Kato M, Kawaratani H, Tanaka K, Yaoita T, Yamaguchi S, Abe K, Kawamura T, Kinoshita Y, Imai K, Fujinami H, Yada T, Miyamoto H, Yoshida H, Fujiwara Y. Continuous warfarin administration versus heparin bridging therapy in post colorectal polypectomy haemorrhage: a study protocol for a multicentre randomised controlled trial (WHICH study). Trials. 2021 Jan 7;22(1):33. doi: 10.1186/s13063-020-04975-y.
36. Y.Watanabe, R.Oikawa, Y.Kodaka, Y.Sato, S.Ono, T.Kenmochi, H.Suzuki, S.Futagami, M.Kato, H.Yamamoto, F.Itoh. Cancer-related genetic variants of Helicobacter pylori strains determined using gastric wash-based whole-genome analysis with single-molecule real-time technology. Int J Cancer. 2021 Jan 1;148(1):178-192.
37. Suzuki H, Yoshitaka T, Yoshio T. and Tada T. Artificial intelligence for cancer detection of the upper gastrointestinal tract. Digestive Endoscopy. 2021 Jan;33(2):254-262.
38. Toshio Suzuki, Yoshiyuki Yamamoto, Noriaki Sakamoto, Hideo Suzuki, Kazuko Tajiri, Tomoko Ishizu, Yasuhiro Fujisawa, Masayuki Noguchi, Masaki Ieda, Yuji Hiramatsu, Ikuo Sekine, Dramatic Recovery From Cardiovascular Collapse: Paclitaxel as an Urgent Treatment for Primary Cardiac Angiosarcoma. Internal Medicine .2021 Jan; 60:67-71.Article ID 5420-20, Advance online publication August 22, 2020
39. Hasegawa H, Taniguchi H, Nakamura Y, Kato T, Fujii S, Ebi H, Shiozawa M, Yuki S, Masuishi T, Kato K, Izawa N, Moriwaki T, Oki E, Kagawa Y, Denda T, Nishina T, Tsuji A, Hara H, Esaki T, Nishida T, Kawakami H, Sakamoto Y, Miki I, Okamoto W, Yamazaki K, Yoshino T. FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer. Cancer Sci. 2021 Jan;112(1):314-322.
40. Moriwaki T, Gosho M, Sugaya A, Yamada T, Yamamoto Y, Hyodo I. Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis.Cancer Res Treat. 2020 Dec 1. doi: 10.4143/crt.2020.805. Epub ahead of print.
41. Kojima T, Shah MA, Muro K, Francois E, Adenis A, Hsu CH, Doi T, Moriwaki T, Kim SB, Lee SH, Bennouna J, Kato K, Shen L, Enzinger P, Qin SK, Ferreira P, Chen J, Girotto G, de la Fouchardiere C, Senellart H, Al-Rajabi R, Lordick F, Wang R, Suryawanshi S, Bhagia P, Kang SP, Metges JP; KEYNOTE-181 Investigators. Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer. J Clin Oncol. 2020 Dec 10;38(35):4138-4148.doi: 10.1200/JCO.20.01888.
42. Hirose S, Kaneko T, Yamaura M. et al. Inflammatory myofibroblastic tumor of ileum with intussusception in adult. Clin J Gastroenterol. 2020 Dec;13(6):1116-1120.
43. Terasaki A, Kurokawa H, Ito H, Komatsu Y, Matano D, Terasaki M, Bando H, Hara H, Matsui H. Elevated Production of Mitochondrial Reactive Oxygen Species via Hyperthermia Enhanced Cytotoxic Effect of Doxorubicin in Human Breast Cancer Cell Lines MDA-MB-453 and MCF-7. International Journal of Molecular Sciences. 2020 Dec 15;21(24):9522.
44. Takahisa WATAHIKI, Kosuke OKADA, Eiji WARABI, Tsugumi NAGAOKA, Hideo SUZUKI, Kazunori ISHIGE, Toru YANAGAWA, Satoru TAKAHASHI, Yuji MIZOKAMI, Katsutoshi TOKUSHIGE, Shun-ichi ARIIZUMI, Masakazu YAMAMOTO, Junichi SHODA.Gender difference in development of steatohepatitis in p62/Sqstm1 and Nrf2 double-knockout mice, Experimental Animals. 2020 Nov 12;69(4):395-406.Article ID 20-0028, Advance online publication June 03, 2020
45. Hirose S, Hasegawa N. and Mizokami Y. Cholesterosis of the common bile duct successfully diagnosed macroscopically and histologically using the transpapillary approach. Digestive Endoscopy. 2020 Nov;32(7):1113-1113.
46. Hasegawa, N., Endo, M. and Terasaki, M. Crush and removal of biliary stones by peroral direct cholangioscopy and W-shaped grasping forceps after hepaticojejunostomy. Digestive Endoscopy. 2020 Nov;32(7):e153-e154.
47. Mizokami Y, Yamamoto T, Atarashi H, Yamashita T, Akao M, et al. Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry. PLOS ONE. 2020 Nov 5;15(11):e0240859.
48. Hiroya Taniguchi, Yasuhiro Koh, Naotoshi Sugimono, Tomohiro Nishina, Takao Tamura, Hiroki Hara, Taito Esaki, Tadamichi Denda, Akitaka Makiyama, Aya Sakai, Hiroyuki Okuda, Naoki Izawa, Takayuki Ando, Kentaro Yamazaki, Shinya Tokunaga, Toshikazu Moriwaki, Akihito Tsuji, Hidekazu Kuramochi, Katsunori Shinozaki, Yukinori Ozaki, Hironori Yamaguchi, Hisateru Yasui, Satoshi Otsu, Mio Ikeda, Junji Kishimoto, Taroh Satoh, Daisuke Sakai, Kei Muro. Biomarker Analysis in A Randomized Phase 2 Study of Panitumumab Versus Cetuximab in Colorectal Cancer (WJOG6510GTR). Journal of Cancer Science and Clinical Therapeutics. 2020 Oct; 4: 538-549.Doi: 10.26502/jcsct.5079093
49. Izawa N, Shitara K, Yonesaka K, Yamanaka T, Yoshino T, Sunakawa Y, Masuishi T, Denda T, Yamazaki K, Moriwaki T, Okuda H, Kondoh C, Nishina T, Makiyama A, Baba H, Yamaguchi H, Nakamura M, Hyodo I, Muro K, Nakajima TE. Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G). Target Oncol. 2020 Oct;15(5):623-633. doi: 10.1007/s11523-020-00750-w.
50. Hasegawa N, Yamaguchi Y, Hattori J. et al. A case of pancreatic-pleural fistula of Type 1 autoimmune pancreatitis successfully treated with pancreatic drainage and steroid. Clin J Gastroenterol. 2020 Oct;13(5):946-950.
51. Hasegawa N, Ito Y, Yamaura M. et al. Splenic rupture caused by pancreatic pseudocyst successfully treated by endoscopic ultrasound-guided drainage. Clin J Gastroenterol. 2020 Oct;13(5):981-984.
52. akayama T, Suzuki H, Okada K, Yamada T, Maruo K, et al. Prediction of true Helicobacter pylori-uninfected status using a combination of age, serum antibody and pepsinogen: Logistic regression analysis. PLOS ONE. 2020 Oct 1;15(10):e0240040.
53. Tomomi Kajiwara, Hiroyuki Ariga, Junya Kashimura. Ceftriaxone pseudolithiasis detected by computed tomography and followed up until resolution. Journal of Rural Medicine. 2020 Oct;15(4):230-233.
54. Kito Y, Satake H, Taniguchi H, Yamada T, Horie Y, Esaki T, Denda T, Yasui H, Izawa N, Masuishi T, Moriwaki T, Mori K, Yamazaki K. Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer. Cancer Chemother Pharmacol. 2020 Aug;86(2):277-284. doi: 10.1007/s00280-020-04116-x. Epub 2020 Jul 24.
55. Sakai D, Taniguchi H, Sugimoto N, Tamura T, Nishina T, Hara H, Esaki T, Denda T, Sakamoto T, Okuda H, Satoh T, Tsushima T, Makiyama A, Tsuda T, Hosokawa A, Kuramochi H, Tokunaga S, Moriwaki T, Yasui H, Ishida H, Tsuji A, Otsu S, Shimokawa H, Baba E, Sato M, Matsumoto S, Ozaki Y, Shinozaki K, Tamagawa H, Goto M, Kadowaki S, Fujii H, Koh Y, Yamazaki K, Hironaka S, Kishimoto J, Boku N, Hyodo I, Muro K. Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G). Eur J Cancer. 2020 Aug;135:11-21. doi: 10.1016/j.ejca.2020.04.014.
56. Araki R, Yamada T, Maruo K, Araki A, Miyakawa R, Suzuki H, Hashimoto K. Gamma-Polyglutamic Acid-Rich Natto Suppresses Postprandial Blood Glucose Response in the Early Phase after Meals: A Randomized Crossover Study. Nutrients. 2020 Aug; 12(8):2374.
57. Tajima Hiroki , Narasaka Toshiaki, Akutsu Daisuke , Suzuki Hideo , Matsui, Hirofumi , Maruo Kazushi, Yamasaki Hiro MD, Mizokami Yuji .The Risks of Exfoliative Esophagitis in Patients with Atrial Fibrillation. Medicine. 2020 Aug14; 99(33): p e21681
58. Hirose S, Moriwaki T, Yamaura M, Suganuma D , Tajima H, Sato M ,Enami C, Yamada T, Yamamoto Y, Sakamoto N , Hyodo I. A case of advanced gastric cancer showing HER2 positivity after chemotherapy. Int Canc Conf J. 2020 Apr 3;9(3):112-115. doi: 10.1007/s13691-020-00412-8. eCollection 2020 Jul.
59. Suguru Hirose, Naoyuki Hasegawa, Hitomi Kawai, Masamichi Yamaura, Tsuneo Mizui, Yoshiki Komatsu, Masaomi Nagase, Masashi Sato, Junji Hattori, Masato Endo, Yoshiyuki Yamamoto, Kazunori Ishige, Kuniaki Fukuda, Ichinosuke Hyodo, Yuji Mizokami. Mediastinal Neuroendocrine Carcinoma Slowly Growing for 8 Years after Surgical Resection of Esophageal Squamous Cell Carcinoma. Internal Medicine. 2020 Jul;59(20): 2505-2509.Article ID 4584-20, Advance online publication July 07, 2020
60. Hirose S, Ishige K, Yamaura, M. et al. A case report: Long-term complete response of metastatic hepatocellular carcinoma obtained after discontinuation of 2-month sorafenib monotherapy. Clin J Gastroenterol. 2020 Jun;13: 902–906.
61. Iwata N, Shikama A, Takao W, Hosokawa Y, Itagaki H, Tasaka N, Akiyama A, Ochi H, Minaguchi T, Arita M, Noguchi E, Moriwaki T, Satoh T. Ovarian metastases from ileum cancer in a patient with germline EPCAM gene deletion successfully treated with surgical resection and CAPOX chemotherapy: a case report.BMC Med Genet. 2020 Apr 9;21(1):76. doi: 10.1186/s12881-020-01013-1.
62. Makiyama A, Sukawa Y, Kashiwada T, Kawada J, Hosokawa A, Horie Y, Tsuji A, Moriwaki T, Tanioka H, Shinozaki K, Uchino K, Yasui H, Tsukuda H, Nishikawa K, Ishida H, Yamanaka T, Yamazaki K, Hironaka S, Esaki T, Boku N, Hyodo I, Muro K. Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study). J Clin Oncol. 2020 Jun 10;38(17):1919-1927. doi: 10.1200/JCO.19.03077. Epub 2020 Mar 24.
63. Yoshino T, Cleary JM, Van Cutsem E, Mayer RJ, Ohtsu A, Shinozaki E, Falcone A, Yamazaki K, Nishina T, Garcia-Carbonero R, Komatsu Y, Baba H, Argilés G, Tsuji A, Sobrero A, Yamaguchi K, Peeters M, Muro K, Zaniboni A, Sugimoto N, Shimada Y, Tsuji Y, Hochster HS, Moriwaki T, Tran B, Esaki T, Hamada C, Tanase T, Benedetti F, Makris L, Yamashita F, Lenz HJ. Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials. Ann Oncol. 2020 Jan;31(1):88-95. doi: 10.1016/j.annonc.2019.10.005.
64. Ueno T, Suzuki H, Hirose M, Shida T, Ikezawa K, Matsui H, Mizokami Y, Yanaka A. Influence of Living Environment during Childhood on Helicobacter pylori Infection in Japanese Young Adults. Digestion. 2020;101(6):779-784.
65. 黒崎 宏貴, 有賀 啓之, 高屋敷 典生, 水井 恒夫, 鹿志村 純也, 粘膜下層剥離術を施行したEBウイルス関連胃癌の一例, Progress of Digestive Endoscopy, 2020, 97 巻, 1 号, p. 71-72
66. 岡田 健太, 有賀 啓之, 熊倉 有里, 鹿志村 純也, 大腸悪性狭窄に対する大腸ステントの有用性について, Progress of Digestive Endoscopy, 2020, 97 巻, 1 号, p. 110-111
67. 福田 壮馬, 遠藤 壮登, 福田 邦明, 辻 実季, 小野田 翼, 丹下 善隆, 新里 悠輔, 寺崎 正彦, 長谷川 直之, 橋本 諒典, 湯口 周, 野口 雅之, 溝上 裕士, 直視下生検で診断し得た肝細胞癌胆管腫瘍栓の1例, Progress of Digestive Endoscopy, 2020, 97 巻, 1 号, p. 136-138
68. 坂倉 明恵, 有賀 啓之, 熊倉 有里, 鹿志村 純也, Lymphoid stromaを伴うEBV関連早期胃癌の1例, Progress of Digestive Endoscopy, 2019-2020, 96 巻, 1 号, p. 93-94
69. 水井 恒夫, 有賀 啓之, 熊倉 有里, 鹿志村 純也, 腸重積をきたした大腸脂肪腫の1例, Progress of Digestive Endoscopy, 2019-2020, 96 巻, 1 号, p. 161-162
70. 辻 実季, 鹿志村 純也, 水井 恒夫, 熊倉 有里, 有賀 啓之, ストレート型胆管ステントが乳頭を穿通した一例, Progress of Digestive Endoscopy, 2019-2020, 96 巻, 1 号, p. 207-209
71. 鄭 黎佳, 鹿志村 純也, 水井 恒夫, 熊倉 有里, 有賀 啓之, 分枝型IPMNを合併した胆管非拡張型の膵・胆管合流異常の一例, Progress of Digestive Endoscopy, 2019-2020, 96 巻, 1 号, p. 213-214
